0000885590-12-000029.txt : 20120514
0000885590-12-000029.hdr.sgml : 20120514
20120514175728
ACCESSION NUMBER: 0000885590-12-000029
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20120514
FILED AS OF DATE: 20120514
DATE AS OF CHANGE: 20120514
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PAUL LAURENCE E
CENTRAL INDEX KEY: 0001190966
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 12840112
MAIL ADDRESS:
STREET 1: LAURE CROWN VENTURE 1620 26TH ST
STREET 2: SOUTH TOWER SUITE 300
CITY: SANTA MONICA
STATE: CA
ZIP: 90404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4787 LEVY STREET
STREET 2: MONTREAL
CITY: QUEBEC
STATE: A8
ZIP: H4R 2P9
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 4787 LEVY STREET
STREET 2: MONTREAL
CITY: QUEBEC
STATE: A8
ZIP: H4R 2P9
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0305
4
2012-05-14
0
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001190966
PAUL LAURENCE E
4787 LEVY STREET
MONTREAL
A8
H4R 2P9
QUEBEC, CANADA
1
0
0
0
Common Stock, no par value
2012-05-14
4
P
0
2100
51.0268
A
34497
D
Common Stock, no par value
2012-05-14
4
P
0
2900
51.03
A
37397
D
This number represents common shares purchased by the officer, as well as other outstanding equity awards that were previously reported in Table 1.
by: Nicholas Zanoni for Larry Paul
2012-05-14
EX-24
2
poapaul.txt
POER OF ATTORNEY
POWER OF ATTORNEY
Know all by these presents that the undersigned hereby constitutes
and appoints each of Robert Chai-Onn, Ling Zeng, Nicholas Zanoni and
Pamela Chronister-Lewis, or any of them signing singly, and with full
power of substitution, the undersigned's true and lawful attorney-in-fact
to:
(1) prepare, execute in the undersigned's name and on the
undersigned's behalf, and submit to the U.S. Securities and
Exchange Commission (the "SEC") a Form ID, including
amendments thereto, and any other documents necessary or
appropriate to obtain codes and passwords enabling the
undersigned to make electronic filings with the SEC of
reports required by Section 16(a) of the Securities Exchange
Act of 1934 (the "Exchange Act") or any rule or regulation of
the SEC;
(2) execute for and on behalf of the undersigned, in the
undersigned's capacity as a director and/or officer of
Valeant Pharmaceuticals International, Inc. (the "Company"),
Forms 3, 4, and 5 in accordance with Section 16(a) of the
Exchange Act and the rules thereunder;
(3) do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete
and execute any such Form 3, 4, or 5, complete and execute
any amendment or amendments thereto, and timely file such
form with the SEC and any stock exchange or similar
authority; and
(4) take any other action of any type whatsoever in connection
with the foregoing which, in the opinion of such attorney-in-
fact, may be of benefit to, in the best interest of, or
legally required by, the undersigned, it being understood
that the documents executed by such attorney-in-fact on
behalf of the undersigned pursuant to this Power of Attorney
shall be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full
power and authority to do and perform any and every act and thing
whatsoever requisite, necessary, or proper to be done in the exercise of
any of the rights and powers herein granted, as fully to all intents and
purposes as the undersigned might or could do if personally present, with
full power of substitution or revocation, hereby ratifying and confirming
all that such attorney-in-fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by virtue of this
power of attorney and the rights and powers herein granted. The
undersigned acknowledges that the foregoing attorneys-in-fact, in serving
in such capacity at the request of the undersigned, are not assuming, nor
is the Company assuming, any of the undersigned's responsibilities to
comply with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until
the undersigned is no longer required to file Forms 3, 4, and 5 with
respect to the undersigned's holdings of and transactions in securities
issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of this 31st day of August, 2011.
/s/Laurence Paul
Signature
Laurence Paul
Name